Renal Cancer: Avastin Prolongs time to disease progression

Avastin is Monoclonal Antibody which in a recent study prolonged to a significant degree the time to disease progression in patients with metastasis metastatic renal cell cancer. [P] Reference: NEJM 2003; 427-434

Webmaster

October 27, 2003